Portfolio company CarlSmed completed its IPO, raising $100.5M on NASDAQ under ticker CARL for personalized spine surgery technology.
Carlsmed is dedicated to advancing personalized spinal solutions through its aprevo® platform, which enhances surgical outcomes and reduces healthcare costs for spine surgery
Carlsmed is dedicated to advancing personalized spinal solutions through its aprevo® platform, which enhances surgical outcomes and reduces healthcare costs for spine surgery.